Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
Holding DGX?
Track your performance easily
DGX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$123.04 - $165.32
Previous Close$153.02
Volume480.37K
Average Volume (3M)829.53K
Market Cap
$17.08B
Enterprise Value$23.40B
Total Cash (Recent Filing)$764.00M
Total Debt (Recent Filing)$6.97B
Price to Earnings (P/E)20.6
Beta0.29
Next Earnings
Jan 30, 2025EPS Estimate
$2.19Next Dividend Ex-Date
Jan 14, 2025Dividend Yield1.93%
Share Statistics
EPS (TTM)7.45
Shares Outstanding111,615,181
10 Day Avg. Volume785,543
30 Day Avg. Volume829,534
Standard Deviation0.09
R-Squared0.27
Alpha0.00163
Financial Highlights & Ratios
PEG Ratio1.87
Price to Book (P/B)2.51
Price to Sales (P/S)1.80
Price to Cash Flow (P/CF)12.00
P/FCF Ratio14.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.45
Enterprise Value/Gross Profit7.66
Enterprise Value/Ebitda16.91
Forecast
1Y Price Target
$173.92Price Target Upside13.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Quest Diagnostics News
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactQuest's acquisition of LifeLabs is expected to be accretive to future earnings per share and add value within three years of deal completion.
Market ExpansionQuest's entrance into the Canadian market is seen as strategic due to favorable demographic trends and a stable reimbursement environment.
Revenue GrowthLifeLabs is expected to generate substantial annual revenue and contribute positively to adjusted earnings per share soon after the acquisition is finalized.
Bears Say
Financial UncertaintyStreet estimates for 2024 and 2025 are varied with different assumptions on acquisitions and PAMA, leading to uncertainty.
Operating PerformanceOperating margin was negatively impacted by weather disruptions and a global IT outage, resulting in missed operating income consensus estimates.
Organic Volume ImpactDGX’s organic volume was negatively impacted by Hurricane/CrowdStrike, exit of low-margin capitated business in CA, and ongoing employer business headwind.
---
Ownership Overview
0.41% Insiders
28.75% Mutual Funds
15.77% Other Institutional Investors
27.34% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DGX FAQ
What was Quest Diagnostics’s price range in the past 12 months?
Quest Diagnostics lowest stock price was $123.04 and its highest was $165.32 in the past 12 months.
What is Quest Diagnostics’s market cap?
Currently, no data Available
When is Quest Diagnostics’s upcoming earnings report date?
Quest Diagnostics’s upcoming earnings report date is Jan 30, 2025 which is in 33 days.
How were Quest Diagnostics’s earnings last quarter?
Quest Diagnostics released its earnings results on Oct 22, 2024. The company reported $2.3 earnings per share for the quarter, beating the consensus estimate of $2.264 by $0.036.
Is Quest Diagnostics overvalued?
According to Wall Street analysts Quest Diagnostics’s price is currently Undervalued.
Does Quest Diagnostics pay dividends?
Quest Diagnostics pays a Quarterly dividend of $0.75 which represents an annual dividend yield of 1.93%. See more information on Quest Diagnostics dividends here
What is Quest Diagnostics’s EPS estimate?
Quest Diagnostics’s EPS estimate is $2.19.
How many shares outstanding does Quest Diagnostics have?
Quest Diagnostics has 111,615,180 shares outstanding.
What happened to Quest Diagnostics’s price movement after its last earnings report?
Quest Diagnostics reported an EPS of $2.3 in its last earnings report, beating expectations of $2.264. Following the earnings report the stock price went up 6.853%.
Which hedge fund is a major shareholder of Quest Diagnostics?
Among the largest hedge funds holding Quest Diagnostics’s share is Davis Selected Advisers. It holds Quest Diagnostics’s shares valued at 372M.
---
Quest Diagnostics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$173.92 (13.95% Upside)
$173.92 (13.95% Upside)
Blogger Sentiment
Bullish
DGX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 523.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $278.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.29%
12-Months-Change
Fundamentals
Return on Equity
12.66%
Trailing 12-Months
Asset Growth
19.38%
Trailing 12-Months
Company Description
Quest Diagnostics
Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
---
DGX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth driven by acquisitions, advanced diagnostics, and operational improvements. However, challenges such as weather impacts, IT outages, and integration of acquisitions affected margins and may pose short-term hurdles.Read More>---
DGX Revenue Breakdown
97.02% Diagnostic Information Services
2.98% All other operating segments
---
DGX Stock 12 Month Forecast
Average Price Target
$173.92
▲(13.95% Upside)
Technical Analysis
Best Analysts Covering DGX
1 Year
1 Year Success Rate
9/14 ratings generated profit
1 Year Average Return
+9.74%
reiterated a buy rating last month
Copying Eric Coldwell's trades and holding each position for 1 Year would result in 64.29% of your transactions generating a profit, with an average return of +9.74% per trade.
---